Anika Therapeutics
ANIK
160 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 15 closing their positions.
67% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 15
19% more capital invested
Capital invested by funds: $406M → $483M (+$77.5M)
5% more funds holding
Funds holding: 153 → 160 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 57
45% less call options, than puts
Call options by funds: $1.89M | Put options by funds: $3.46M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$15.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.6M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$12.3M |
| 4 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
+$5.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$8.04M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$5.7M |
| 3 |
Morgan Stanley
New York
|
-$4.66M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.26M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.38M |
ANIK Hedge Fund Activity: Q4 2014 in Review
160 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2014, worth a combined $483M — up 19% from $406M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ANIK positions and 15 closed out — a net gain of 10 holders — while 56 added to existing stakes and 57 trimmed.
The largest buyer was Ranger Investment Management, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $8.04M.
- 160 institutional investors held Anika Therapeutics (ANIK) as of Q4 2014, up from 153 in Q3 2014.
- Funds reported $483M of Anika Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
- 25 funds opened new Anika Therapeutics positions in Q4 2014 and 15 closed out, a net change of +10 holders.
- The largest Anika Therapeutics buyer in Q4 2014 was Ranger Investment Management, an estimated $15.4M added.
- The largest Anika Therapeutics seller in Q4 2014 was Millennium Management, an estimated $8.04M sold.
Based on aggregated 13F filings for Q4 2014.